Sales

The appointment of Brian Niccol as the new chief executive and chair of Starbucks has sparked a wave of optimism among investors and analysts on Wall Street. With the goal of propelling the iconic coffee chain beyond the shadow of the Howard Schultz era, Niccol is tasked with breathing new life into the company’s struggling
0 Comments
In a recent market update, Citi Research has expressed a growing bearish sentiment towards risk assets and has advised investors to sell any rallies in the EUR/USD currency pair. Despite a slight uptick in EUR/USD trading by 0.1% to $1.0926, there has been a general downward trend over the past week. Citi Research highlighted concerns
0 Comments
Morgan Stanley’s focus on defensive quality stocks has become more pronounced in recent months, according to its chief U.S. equity strategist, Michael Wilson. Despite the ongoing surge of major U.S. indexes to record highs, the firm continues to emphasize the importance of defensive positioning in investor portfolios. Wilson believes that amidst increasing market volatility, investors
0 Comments
General Motors recently unveiled the redesigned versions of their entry-level GMC Terrain crossover, with a new standard “Elevation” model. This compact crossover boasts a more rugged exterior design and an updated interior featuring 26 inches of screens. These screens include a 15-inch center touchscreen and an 11-inch driver information cluster, offering a modern and tech-savvy
0 Comments
Restaurant CEOs are constantly facing the pressure of explaining to investors why their sales are not meeting expectations. In recent times, the word “value” has become a focal point in these discussions, highlighting the industry‘s biggest concern. The current economic climate has seen a significant increase in food prices away from home, leading to a
0 Comments
The recent global market volatility has brought China’s distinct market status to the forefront, showcasing that even with a recent slowdown in growth, Chinese stocks have remained relatively stable compared to their counterparts. While U.S. tech stocks and Japanese stocks experienced significant fluctuations over the past few days, Chinese stocks saw lesser impacts, with the
0 Comments
Eli Lilly’s second-quarter earnings report for this year has exceeded expectations, leading to a significant increase in their full-year revenue outlook. The company reported impressive sales figures for its diabetes drug Mounjaro and weight loss injection Zepbound, causing its stock price to surge in premarket trading. With a revised guidance for adjusted earnings and revenue
0 Comments